Safety and Tolerability of IBI355 in Patients With Primary Sjogren's Syndrome
Clinical trial NCT06484855 · COMPLETED
Trial details
- NCT number
- NCT06484855
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-14
- Primary completion
- 2025-06-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.